Abstract
In order to obtain novel bioactive compounds with significant antifungal activities, two series of 3-substituted phthalide derivatives were designed and synthesized via reduction, bromine substitution, and etherification. In addition, the antifungal activities of all target compounds against nine phytopathogenic fungi in vitro were tested by using the mycelial growth rate method at the concentration of 50 μg mL−1. Preliminary bioassay tests showed that some compounds exhibited more potent antifungal activities as compared with hymexazol. The preliminary structure-activity relationships (SARs) of all target compounds were also investigated.
1 Introduction
Phytopathogenic fungi easily infect many crops and are often hard to control. Therefore, the development of new compounds that effectively inhibit these agricultural diseases is still highly desirable. Phthalide is an important heterocyclic scaffold found in several plants [1]. Molecules containing this pharmacophore exhibit a broad spectrum of biological activities [2], such as antioxidant [3], analgesic [4], antithrombotic [5], antiplatelet [6], insecticidal [7], [8], [9], bactericidal [10], antifungal [11], and anti-HIV [12], [13] activities. For example, 3-n-butylphthalide (NBP) (Fig. 1), an antiplatelet drug, which was approved in 2002 by the State Food and Drug Administration of China for the clinical treatment of acute ischemic stroke [14]. Mycophenolic acid (MPA) is in clinical trial for the prevention and reversal of transplant rejection and as an anticancer drug [15]. Corollosporine is a new phthalide derivative from the marine fungus Corollospora maritima which exhibits concentration-dependent antibacterial activity against Staphylococcus aureus and other microorganisms [16]. (±)-Chrycolide is isolated from the leaves and stem of a popular vegetable Chrysanthemum coronarium, which shows plant growth inhibiting activity [17].

Selected biologically important compounds containing a phthalide scaffold.
Encouraged by the numerous pharmacological activities of phthalide derivatives, and in continuation of our ongoing work on the discovery and development of compounds with superior antifungal activities [18], [19], we prepared two series of 3-substitued phthalide derivatives and evaluated their antifungal activities against nine phytopathogenic fungi in vitro.
2 Results and discussion
As shown in Scheme 1, isobenzofuran-1(3H)-one (1) was prepared by the reduction of phthalic anhydride with sodium borohydride (NaBH4), followed by cyclization in 3 n hydrochloric acid (HCl) at room temperature. Compound 1 was then subjected to radical bromination in the presence of N-bromosuccinimide/azobisisobutyronitrile (NBS/AIBN) to give the key intermediate 2. Finally, two series of 3-substituted phthalide derivatives (3a–j and 4a–m) were synthesized from intermediate 2 by Williamson etherification reaction in the presence of potassium carbonate (K2CO3). To our surprise, 5-methyl-2-(3-oxo-1,3-dihydroisobenzofuran-1-yl)-3-(3-oxo-1,3-dihydroisobenzofuran-1-yloxy)is-oxazol bromide (3j) was obtained when compound 2 reacted with the nucleophile 5-methylisoxazol-3-ol (5) under the same conditions. Closer scrutiny of this reaction revealed that it was completely determined by the reaction time. If the reaction time was prolonged to 12 h, compound 3i was immediately and completely transformed into the unexpected quaternary salt 3j [20]. The structures of all target compounds were characterized by 1H nuclear magnetic resonance (NMR), 13C NMR and high-resolution mass spectrometry.

Synthetic route of the preparation of phthalide derivatives 3a–j and 4a–m.

The conversion of compound 3i–j.
The antifungal activities of 3-substituted phthalide derivatives 3a–j and 4a–m against nine phytopathogenic fungi [i.e. Fusarium solani (FS), Botryosphaeria berengriana f. sp. Piricola (BP), Curvularia lunata (CL), Fusarium oxysporum schlecht. f. sp. C. maxima (FM), Fusarium graminearum (FG), Alternaria alternata (AA), Pyricularia oryzae (PO), Fusarium oxysporum f. sp. Vasinfectum (FV), and Alternaria brassicae (AB)] were investigated at a concentration of 50 μg mL−1in vitro by the poisoned food technique [21]. Hymexazol, a commercially available agricultural fungicide, was used as a positive control at the same concentration (50 μg mL−1).
As is shown in Table 1, the results revealed that most of derivatives displayed certain inhibitory effects on the growth of the tested phytopathogenic fungi. Among all the synthesized compounds, ten derivatives 3b, 3c, 3e, 3f, 3g, 3i, 3j, 4a, 4c, and 4j (42, 48, 43, 53, 52, 45, 41, 44, 41, 50%, respectively) generally exhibited more pronounced antifungal activity against BP than hymexazol (31%). This finding indicated that the synthesized 3-substituted phthalide derivatives could represent a new structure skeleton for inhibiting BP. Compounds 3b, 3c, 3f, 3g, 3i, 4c, 4j, and 4k (45, 43, 58, 46, 53, 44, 52, 51%, respectively) showed relatively higher activity against FS than hymexazol (42%). Preliminary structure-activity relationships (SARs) presumed that introduction electron-donating groups -OH and -NH2 on the benzene ring could enhance their antifungal activity against FS, probably because they form a hydrogen bond with the active site of the enzyme in the fungus leading to metabolic system disorder [22]. For FV strains, compounds 3b, 3j, 4c, 4j, 4k, and 4m (38, 43, 38, 37, 39, 39%, respectively) displayed slightly higher inhibition rates than hymexazol (37%). Toward FG strains, the introduction of two nitrogen dioxide (-NO2) group or -OH group on the benzene ring give the compounds 3e (62%) and 3f (52%), which show better activities than hymexazol (52%). For CL strains, seven compounds 3c (48%), 3g (41%), 3j (43%), 4c (56%), 4j (55%), 4k (61%), and 4m (42%) display more potent antifungal activities than hymexazol (40%). In addition, all compounds showed poor fungicidal activities against the four tested fungi (FM, AA, PO, and AB) except compounds 3c, 3i, 4c, 4j, and 4k. Based on these results compounds 3c, 4c, 4j, and 4k provide broad-spectrum antifungal activities to the tested fungi and could be taken under consideration for further research.
Antifungal activities of compounds at 50 μg mL−1.
| Compounds | Antifungal activities (inhibition %±SE)a | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| FS | FV | FM | FG | CL | BP | AA | PO | AB | |
| 3a | 5 (±1) | 9 (±1) | 8 (±3) | 10 (±1) | – | 9 (±1) | 6 (±1) | 16 (±1) | 12 (±1) | 
| 3b | 45 (±2) | 38 (±2) | 28 (±1) | 48 (±1) | 38 (±1) | 42 (±1) | 31 (±2) | 22 (±1) | 29 (±2) | 
| 3c | 43 (±3) | 34 (±2) | 47 (±2) | 49 (±2) | 48 (±4) | 48 (±4) | 43 (±1) | 41 (±1) | 47 (±1) | 
| 3d | 14 (±1) | 27 (±1) | 27 (±2) | 40 (±1) | 29 (±1) | 34 (±1) | 26 (±1) | 18 (±3) | 20 (±1) | 
| 3e | 12 (±3) | 29 (±1) | 33 (±1) | 62 (±2) | 35 (±3) | 43 (±2) | 26 (±2) | 29 (±3) | 30 (±1) | 
| 3f | 58 (±1) | 31 (±1) | 30 (±1) | 52 (±1) | 32 (±1) | 53 (±2) | 38 (±1) | 37 (±1) | 32 (±1) | 
| 3g | 46 (±2) | 34 (±1) | 32 (±1) | 22 (±1) | 41 (±2) | 52 (±2) | 24 (±3) | 21 (±4) | 38 (±1) | 
| 3h | 2 (±2) | 15 (±3) | 39 (±2) | 33 (±1) | 22 (±2) | 19 (±2) | 15 (±2) | 7 (±1) | 24 (±1) | 
| 3i | 53 (±1) | 37 (±2) | 36 (±2) | 19 (±1) | 28 (±1) | 45 (±1) | 54 (±1) | 44 (±1) | 32 (±2) | 
| 3j | 34 (±1) | 43 (±1) | 44 (±1) | 43 (±1) | 43 (±1) | 41 (±2) | 20 (±3) | 23 (±3) | 35 (±1) | 
| 4a | 10 (±2) | 25 (±1) | 29 (±1) | 44 (±3) | 30 (±1) | 44 (±1) | 28 (±1) | 27 (±1) | 29 (±1) | 
| 4b | 17 (±1) | 9 (±1) | 12 (±1) | 1 (±1) | 22 (±2) | 28 (±1) | 5 (±1) | 22 (±1) | 15 (±1) | 
| 4c | 44 (±2) | 38 (±2) | 35 (±1) | 39 (±1) | 56 (±2) | 41 (±1) | 50 (±1) | 45 (±1) | 50 (±2) | 
| 4d | 2 (±2) | 10 (±2) | 10 (±1) | – | 20 (±1) | 14 (±2) | 19 (±2) | 18 (±3) | 13 (±2) | 
| 4e | 1 (±1) | 13 (±1) | 17 (±1) | 8 (±1) | 33 (±1) | 13 (±2) | 8 (±1) | 13 (±3) | 16 (±1) | 
| 4f | 17 (±1) | 18 (±1) | 30 (±1) | 16 (±3) | 30 (±1) | 13 (±2) | 23 (±1) | 24 (±1) | 22 (±1) | 
| 4g | 4 (±1) | 15 (±1) | 18 (±2) | 9 (±1) | 25 (±1) | 20 (±2) | 23 (±2) | 17 (±1) | 29 (±6) | 
| 4h | 15 (±2) | 8 (±4) | 21 (±3) | 5 (±2) | 33 (±1) | – | 20 (±1) | 20 (±4) | 22 (±1) | 
| 4i | 29 (±2) | 25 (±1) | 24 (±1) | 33 (±1) | 33 (±1) | 22 (±2) | 19 (±1) | 22 (±3) | 31 (±1) | 
| 4j | 52 (±2) | 37 (±1) | 50 (±1) | 39 (±1) | 55 (±1) | 50 (±3) | 43 (±1) | 45 (±1) | 45 (±1) | 
| 4k | 51 (±1) | 39 (±1) | 47 (±2) | 43 (±1) | 61 (±1) | 33 (±1) | 42 (±1) | 50 (±4) | 47 (±1) | 
| 4l | 23 (±2) | 17 (±3) | 18 (±1) | 26 (±4) | 31 (±1) | 20 (±2) | 11 (±2) | 19 (±1) | 21 (±2) | 
| 4m | 31 (±2) | 39 (±1) | 43 (±1) | 44 (±1) | 42 (±1) | 27 (±1) | 33 (±1) | 30 (±1) | 36 (±2) | 
| Hymb | 42 (±3) | 37 (±1) | 51 (±1) | 52 (±1) | 40 (±3) | 31 (±1) | 69 (±1) | 69 (±3) | 53 (±1) | 
aValues are the mean±SE of three replicates. bHym, hymexazol.
3 Conclusion
In conclusion, 24 3-substituted phthalide derivatives were designed and synthesized via reduction, bromine substitution and Williams etherification, and evaluated in vitro for their antifungal activities against nine phytopathogenic fungi at the concentration of 50 μg mL−1. Among these derivatives, four compounds 3c, 4c, 4j, and 4k generally exhibit broad-spectrum antifungal activities as compared with the commercially available agricultural fungicide hymexazol. This clearly demonstrates that the introduction of appropriate thioether and oxyether substituents on the 3-position of phthalide leads to more potent antifungal derivatives.
4 Experimental section
4.1 General information
All reagents and solvents were of reagent grade or purified according to standard methods before use. Thin-layer chromatography (TLC) and preparative thin-layer chromatography (PTLC) were used with silica gel 60 GF254 (Qingdao Haiyang Chemical Co., Ltd., China). Melting points (m. p.) were determined on a digital m.p. apparatus and were uncorrected. 1H NMR and 13C NMR spectra were recorded on a Bruker Avance NEO 600 MHz and 150 MHz instruments, respectively, using TMS as the internal standard and CDCl3 or DMSO-d6 as the solvent. High-resolution mass spectra (HRMS) were carried out with an APEX II Bruker 4.7T AS instrument.
4.1.1 Synthesis of isobenzofuran-1(3H)-one (1)
Phthalic anhydride (10.0 g, 67.5 mmol) was dissolved in tetrahydrofuran (THF) (200 mL) then sodium borohydride (NaBH4) (2.6 g, 67.5 mmol) was added in portions at T=0–5°C. The resulting mixture was stirred for 13 h at room temperature. The reaction mixture was acidified with 3 n HCl to pH=1 and stirred for an additional 10.5 h. The solvent was removed under reduced pressure and the residue was extracted with ethyl acetate (2×250 mL), which was then washed with 10% K2CO3 aqueous solution (3×100 mL), brine (150 mL), and dried over sodium sulfate (Na2SO4). The solvent was evaporated to dryness under reduced pressure to give compound 1 (7.4 g, 81.9%) as a white solid; m. p. 74–75°C (lit. [23]: 72–73°C).
4.1.2 Synthesis of 3-bromoisobenzofuran-1(3H)-one (2)
Isobenzofuran-1(3H)-one (6.6 g, 49.6 mmol), NBS (9.7 g, 54.5 mmol) and AIBN (0.8 g, 4.9 mmol) were diluted in dry carbon tetrachloride (CCl4) (200 mL) and heated to 72°C for 2.5 h. The mixture was cooled to room temperature overnight, filtered, and the residue was washed with petroleum ether. The filtrate was concentrated in vacuo to provide the crude product, which was recrystallized from cyclohexane to give 2 (8.6 g, 81.8%) as a light brown solid; m. p. 79–82°C (lit. [24]: 76–78°C). – 1H NMR (600 MHz, CDCl3): δ=7.65 (d, 1H, J=7.2 Hz), 7.80–7.77 (m, 1H), 7.64–7.61 (m, 2H), 7.41 (s, 1H). – 13C NMR (150 MHz, CDCl3): δ=167.3, 148.8, 135.2, 130.9, 125.9, 124.0, 123.5, 74.6.
4.2 General procedure for the synthesis of compounds 3a–j and 4a–m
In a 50 mL round-bottom flask containing 5 mL acetone, anhydrous K2CO3 (0.5 mmol), compound 2 (0.5 mmol) and substituted phenol or benzenethiol (0.5 mmol) were added and reacted at room temperature under N2. When the reaction was complete (TLC control), the organic solvent was removed, followed by addition of water (20 mL). The solution was extracted with ethyl acetate (EtOAc) (3×30 mL). Finally, the resulting organic phases was washed with brine, dried over anhydrous Na2SO4 and evaporated under reduced pressure. The crude material was purified by silica gel column chromatography to give desired products 3a–j and 4a–m, which were characterized by 1H NMR, 13C NMR and HRMS.
4.2.1 (R/S)-3-(2-nitrophenoxy)isobenzofuran-1(3H)- one (3a)
Yield: 50.1%, white solid; m. p. 192–194°C. – 1H NMR (600 MHz, DMSO-d6): δ=8.03–7.93 (m, 3H), 7.89–7.79 (m, 3H), 7.73 (dd, 1H, J=8.4 Hz, 1.2 Hz), 7.42 (s, 1H), 7.41–7.37 (m, 1H). – 13C NMR (150 MHz, DMSO-d6): δ=168.0, 149.0, 144.4, 141.1, 136.0, 135.3, 132.3, 126.1, 125.8, 125.1, 124.6, 119.1, 100.1. – HRMS [(+)-(electrospray ionization [ESI])]: m/z=294.0376 (calcd. 294.0378 for C14H9NO5Na, [M+Na]+).
4.2.2 (R/S)-3-(2-hydroxyphenoxy)isobenzofuran-1(3H)-one (3b)
Yield: 55.6%, white solid; m. p. 128–130°C. – 1H NMR (600 MHz, DMSO-d6): δ=9.50 (s, 1H, OH), 7.89–7.85 (m, 3H), 7.73–7.29 (m, 1H), 7.69–7.18 (dd, 1H, J=6.4 Hz, 1.2 Hz), 7.10 (s, 1H), 6.97–6.93 (m, 1H), 6.90 (dd, 1H, J=8.0 Hz, 1.6 Hz), 6.79–6.75 (m, 1H). – 13C NMR (150 MHz, DMSO-d6): δ=168.5, 148.5, 145.2, 144.5, 135.5, 131.9, 126.7, 125.4, 125.2, 125.1, 119.7, 119.6, 117.4, 101.2. – HRMS [(+)-(ESI)]: m/z=243.0660 (calcd. 243.0657 for C14H11O4, [M+H]+).
4.2.3 (R/S)-3-(4-tert-butyl-2-hydroxyphenoxy)isobenzofuran-1(3H)-one (3c)
Yield: 62.5%, white solid; m. p. 135–139°C. – 1H NMR (600 MHz, DMSO-d6): δ=9.40 (s, 1H, OH), 7.90–7.89 (m, 3H), 7.77–7.73 (m, 1H), 7.15 (d, 1H, J=7.6 Hz), 7.08 (s, 1H), 6.95 (d, 1H, J=6.4 Hz), 6.84 (dd, 1H, J=8.4 Hz, 2.0 Hz), 1.24 (s, 9H). – 13C NMR (150 MHz, DMSO-d6): δ=168.5, 147.9, 147.8, 145.2, 142.3, 135.5, 131.8, 126.7, 125.4, 125.0, 119.3, 116.4, 114.5, 101.6, 34.5, 31.7. – HRMS [(+)-(ESI)]: m/z=299.1285 (calcd. 299.1283 for C18H19O4, [M+H]+).
4.2.4 (R/S)-N-(4-(3-oxo-1,3-dihydroisobenzofuran-1-yloxy)phenyl)acetamide (3d)
Yield: 54.8%, white solid; m. p. 194–196°C. – 1H NMR (600 MHz, DMSO-d6): δ=9.99 (s, 1H, NH), 7.95–7.89 (m, 3H), 7.78–7.76 (m, 1H), 7.60 (d, 2H, J=8.4 Hz), 7.25 (s, 1H), 7.17 (d, 2H, J=8.4 Hz), 2.03 (s, 3H, COCH3). – 13C NMR (150 MHz, DMSO-d6): δ=168.5, 168.4, 152.0, 145.0, 135.7, 135.6, 132.01, 132.00, 126.4, 125.6, 125.0, 120.8, 117.7, 100.1, 24.4. – HRMS [(+)-(ESI)]: m/z=284.0927 (calcd. 284.0923 for C16H14NO4, [M+H]+).
4.2.5 (R/S)-3-(2,4-dinitrophenoxy)isobenzofuran-1(3H)-one (3e)
Yield: 58.7%, white solid; m. p. 181–182°C. – 1H NMR (600 MHz, DMSO-d6): δ=8.87 (d, 1H, J=2.8 Hz), 8.71 (dd, 1H, J=9.2 Hz, 2.0 Hz), 8.02–7.99 (m, 1H), 7.97–7.93 (m, 2H), 7.90 (d, 1H, J=7.6 Hz), 7.85 (td, 1H, J=8.8 Hz, 0.8 Hz), 7.61 (s, 1H). – 13C NMR (150 MHz, DMSO-d6): δ=167.7, 153.5, 143.8, 142.3, 140.0, 136.2, 132.6, 130.3, 126.0, 125.8, 125.2, 121.9, 118.8, 99.2. – HRMS [(+)-(ESI)]: m/z=317.0334 (calcd. 317.0332 for C14H9N2O7, [M+H]+).
4.2.6 (R/S)-3-(4-hydroxyphenoxy)isobenzofuran-1(3H)-one (3f)
Yield: 83.9%; m. p. 183–185°C. – 1H NMR (600 MHz, DMSO-d6): δ=9.28 (s, 1H, OH), 7.92–7.87 (m, 3H), 7.75–7.74 (m, 1H), 7.05 (d, 2H, J=8.4 Hz), 6.72 (d, 2H, J=8.4 Hz), 6.56 (s, 1H). – 13C NMR (150 MHz, DMSO-d6): δ=168.4, 154.0, 150.2, 149.0, 145.1, 135.5, 131.8, 126.5, 125.4, 119.1, 116.1, 101.0. – HRMS [(+)-(ESI)]: m/z=243.0659 (calcd. 243.0656 for C14H11O4, [M+H]+).
4.2.7 (R/S)-3-(3-aminophenoxy)isobenzofuran-1(3H)-one (3g)
Yield: 68.5%, white solid; m. p. 85–87°C. – 1H NMR (600 MHz, DMSO-d6): δ=7.90 (d, 1H, J=7.2 Hz), 7.76 (d, 1H, J=7.2 Hz), 7.71 (d, 1H, J=7.2 Hz), 7.64 (d, 1H, J=7.2 Hz), 7.56 (d, 1H, J=7.2 Hz), 7.05 (t, 1H, J=7.8 Hz), 6.99 (t, 1H, J=7.8 Hz), 6.92 (s, 1H), 6.87 (d, 1H, J=7.6 Hz). – 13C NMR (150 MHz, DMSO-d6): δ=169.8, 155.7, 142.4, 133.7, 132.8, 131.2, 130.2, 125.7, 125.1, 124.5, 121.9, 117.0, 109.7, 95.5. – HRMS [(+)-(ESI)]: m/z=242.0819 (calcd. 242.0817 for C14H12NO3, [M+H]+).
4.2.8 (R/S)-3-(naphthalen-1-yloxy)isobenzofuran-1(3H)-one (3h)
Yield: 88.1%, white solid; m. p. 153–155°C. – 1H NMR (600 MHz, DMSO-d6): δ=8.07 (d, 1H, J=8.4 Hz), 8.01 (d, 2H, J=8.4 Hz), 7.98 (t, 2H, J=7.2 Hz), 7.83 (t, 1H, J=7.2 Hz), 7.73 (d, 1H, J=7.8 Hz), 7.59–7.53 (m, 3H), 7.50 (d, 1H, J=7.8 Hz), 7.47 (s, 1H). – 13C NMR (150 MHz, DMSO-d6): δ=168.3, 152.3, 145.1, 135.8, 134.6, 132.0, 128.1, 127.2, 126.3, 125.5, 125.0, 123.4, 121.7, 110.2, 100.1. – HRMS [(+)-(ESI)]: m/z=277.0869 (calcd. 277.0865 for C18H13O3, [M+H]+).
4.2.9 (R/S)-3-(5-methylisoxazol-3-yloxy)isobenzofuran-1(3H)-one (3i)
Yield: 20.3%, white solid; m. p. 153–154°C. – 1H NMR (600 MHz, CDCl3): δ=7.99 (d, 1H, J=7.8 Hz), 7.80–7.78 (m, 1H), 7.70 (t, 1H, J=7.8 Hz), 7.63 (d, 1H, J=7.2 Hz), 7.28 (s, 1H), 5.56 (s, 1H), 2.14 (s, 3H, CH3). – 13C NMR (150 MHz, CDCl3): δ=174.7, 170.9, 167.9, 142.2, 134.8, 131.1, 127.2, 125.9, 123.2, 97.9, 82.3, 13.7. – HRMS [(+)-(ESI)]: m/z=232.0612 (calcd. 232.0610 for C12H10NO4, [M+H]+).
4.2.10 (R/S)-5-methyl-2-(3-oxo-1,3-dihydroisobenzofuran-1-yl)-3-(3-oxo-1,3-dihydroisobenzofuran-1-yloxy)isoxazol bromide (3j)
Yield: 40.2%, white solid; m. p. 161–164°C. – 1HNMR (600 MHz, CDCl3): δ=8.00–7.99 (m, 1H), 7.95 (d, 1H, J=7.8 Hz), 7.92–7.90 (m, 1H), 7.86–7.80 (m, 4H), 7.77 (t, 1H, J=7.2 Hz), 7.69 (s, 1H), 6.12 (s, 1H), 2.22 (s, 3H). – 13CNMR (150 MHz, DMSO-d6) δ=168.0, 167.2, 166.6, 165.3, 165.0, 144.3, 135.8, 133.5, 132.8, 132.1, 131.0, 130.5, 130.5, 129.5, 125.8, 125.7, 124.8, 107.4, 93.9, 18.7. – HRMS [(+)-(ESI)]: m/z=364.0846 (calcd. 364.0849 for C20H14NO6+, [M]+).
4.2.11 (R/S)-3-(2,3-dichlorophenylthio)isobenzofuran-1(3H)-one (4a)
Yield: 89.1%, white solid; m. p. 162–163°C. – 1H NMR (600 MHz, CDCl3): δ=7.92 (d, 1H, J=7.8 Hz), 7.77–7.70 (m, 3H), 7.62 (t, 1H, J=7.8 Hz), 7.42 (d, 1H, J=8.4 Hz), 7.24 (d, 1H, J=7.8 Hz), 6.84 (s, 1H). – 13C NMR (150 MHz, DMSO-d6): δ=168.8, 145.1, 134.6, 134.4, 133.8, 133.1, 130.6, 130.5, 130.0, 127.8, 126.1, 125.8, 123.5, 84.9. – HRMS [(+)-(ESI)]: m/z=310.9702 (calcd. 310.9700 for C14H9Cl2O2S, [M+H]+).
4.2.12 (R/S)-3-(4-chlorophenylthio)isobenzofuran-1(3H)-one (4b)
Yield: 70.5%, white solid; m. p. 116–118°C. – 1H NMR (600 MHz, CDCl3): δ=7.83 (d, 1H, J=7.2 Hz), 7.73 (t, 1H, J=6.6 Hz), 7.67 (d, 1H, J=7.8 Hz), 7.56 (t, 1H, J=7.2 Hz), 7.45–7.43 (m, 2H), 7.26–7.24 (m, 2H), 6.70 (s, 1H). – 13C NMR (150 MHz, DMSO-d6): δ=168.9, 145.8, 135.5, 135.2, 134.4, 130.1, 129.2, 128.4, 126.2, 125.6, 123.3, 86.1. – HRMS [(+)-(ESI)]: m/z=277.0092 (calcd. 277.0090 for C14H10O2SCl, [M+H]+).
4.2.13 (R/S)-3-(2-chlorophenylthio)isobenzofuran-1(3H)-one (4c)
Yield: 65.7%, white solid; m. p. 85–88°C. – 1H NMR (600 MHz, CDCl3): δ=7.86 (d, 1H, J=7.8 Hz), 7.77–7.74 (m, 1H), 7.68 (d, 1H, J=7.2 Hz), 7.58 (t, 1H, J=7.2 Hz), 7.53 (s, 1H), 7.46 (dd, 1H, J=7.8, 1.2 Hz), 7.30–7.29 (m, 1H), 7.26 (t, 1H, J=7.8 Hz), 6.71 (s, 1H). – 13C NMR (150 MHz, DMSO-d6): δ=168.9, 145.6, 134.7, 134.4, 132.8, 132.6, 131.3, 130.1, 129.0, 126.2, 125.6, 123.4, 86.1. – HRMS [(+)-(ESI)]: m/z=277.0091 (calcd. 277.0090 for C14H10O2SCl, [M+H]+).
4.2.14 (R/S)-3-(4-bromophenylthio)isobenzofuran-1(3H)-one (4d)
Yield: 80.6%, white solid; m. p. 139–141°C (lit. [25]: 142–144°C). – 1H NMR (600 MHz, CDCl3): δ=7.84 (d, 1H, J=7.8 Hz), 7.75 (t, 1H, J=7.8 Hz), 7.67 (d, 1H, J=7.8Hz), 7.56 (t, 1H, J=7.2 Hz), 7.42–7.37 (m, 4H), 6.71 (s, 1H). 13C NMR (150 MHz, DMSO-d6): δ=168.9, 145.8, 135.3, 134.4, 132.2, 129.2, 126.2, 125.6, 123.6, 123.3, 86.0. – HRMS [(+)-(ESI)]: m/z=320.9590 (calcd. 320.9586 for C14H10O2SBr, [M+H]+).
4.2.15 (R/S)-3-(3-bromophenylthio)isobenzofuran-1(3H)-one (4e)
Yield: 81.0%, white solid; m. p. 110–112°C (lit. [25]: 114–116°C). – 1H NMR (600 MHz, CDCl3): δ=7.84 (d, 1H, J=7.2 Hz), 7.73 (t, 1H, J=7.2 Hz), 7.65–7.64 (m, 2H), 7.56 (t, 1H, J=7.2 Hz), 7.49–7.47 (m, 1H), 7.43–7.42 (m, 1H), 7.18 (t, 1H, J=7.8 Hz), 6.73 (s, 1H). – 13C NMR (150 MHz, DMSO-d6): δ=168.9, 145.6, 135.6, 134.4, 132.8, 131.9, 131.8, 130.4, 130.3, 126.2, 125.6, 123.4, 122.6, 86.1. – HRMS [(+)-(ESI)]: m/z=320.9591 (calcd. 320.9586 for C14H10O2SBr, [M+H]+).
4.2.16 (R/S)-3-[(4-Fluorophenyl)thio]isobenzofuran-1(3H)-one (4f)
Yield: 83.2%, white solid; m. p. 103–105°C (lit. [25]: 112–114°C). – 1H NMR (600 MHz, CDCl3): δ=7.77 (d, 1H, J=7.8 Hz), 7.72–7.69 (m, 2H), 7.65 (d, 1H, J=7.8 Hz), 7.51 (t, 1H, J=7.2 Hz), 7.46–7.44 (m, 2H), 6.95–6.92 (m, 1H), 6.65 (s, 1H). – 13C NMR (150 MHz, CDCl3): δ=168.9, 164.3, 162.6, 146.0, 136.8, 136.7, 134.3, 130.0, 126.2, 125.4, 124.6, 123.3, 116.2, 86.2. – HRMS [(+)-(ESI)]: m/z=261.0390 (calcd. 261.0386 for C14H10O2FS, [M+H]+).
4.2.17 (R/S)-3-[(3-Fluorophenyl)thio]isobenzofuran-1(3H)-one (4g)
Yield: 72.5%, white solid; m. p. 91–94°C. – 1H NMR (600 MHz, CDCl3): δ=7.86 (d, 1H, J=7.2 Hz), 7.76–7.74 (m, 1H), 7.68 (d, 1H, J=7.8 Hz), 7.58 (t, 1H, J=7.2 Hz), 7.35–7.34 (m, 1H), 7.30–7.26 (m, 2H), 7.04–7.00 (m, 1H), 6.77 (s, 1H). – 13C NMR (150 MHz, CDCl3): δ=168.9, 163.2, 161.6, 145.6, 134.4, 132.7, 130.4, 128.8, 126.2, 125.6, 123.3, 120.0, 116.0, 86.0. – HRMS [(+)-(ESI)]: m/z=261.0387 (calcd. 261.0386 for C14H10O2FS, [M+H]+).
4.2.18 (R/S)-3-(2,6-dimethylphenylthio)isobenzofuran-1(3H)-one (4h)
Yield: 85.4%, white solid; m. p. 128–130°C. – 1H NMR (600 MHz, CDCl3): δ=7.93 (d, 1H, J=7.2 Hz), 7.76–7.73 (m, 2H), 7.62–7.59 (m, 1H), 7.24–7.22 (m, 1H), 7.20–7.19 (m, 2H), 6.51 (s, 1H), 2.68 (s, 6H). – 13C NMR (150 MHz, CDCl3): δ=169.2, 146.4, 143.9, 134.3, 130.1, 129.8, 129.8, 128.6, 126.1, 125.6, 123.3, 88.1, 22.4. – HRMS [(+)-(ESI)]: m/z=271.0792 (calcd. 271.0790 for C16H15O2S, [M+H]+)
4.2.19 (R/S)-3-(3-nitrophenylthio)isobenzofuran-1(3H)-one (4i)
Yield: 87.6%, white solid; m. p. 177–178°C. – 1H NMR (600 MHz, CDCl3): δ=8.19 (dd, 2H, J=7.2 Hz, 2.4 Hz), 7.93 (d, 1H, J=7.8 Hz), 7.80–7.77 (m, 1H), 7.72–7.68 (m, 3H), 7.64 (t, 1H, J=7.8 Hz), 6.89 (s, 1H). – 13C NMR (150 MHz, CDCl3): δ=168.5, 147.3, 145.0, 141.0, 134.7, 131.3, 130.7, 126.1, 126.0, 124.1, 123.3, 84.8. – HRMS [(+)-(ESI)]: m/z=287.0257 (calcd. 287.0253 for C14H10NO4S, [M+H]+).
4.2.20 (R/S)-3-(4-(trifluoromethyl)phenylthio)isobenzofuran-1(3H)-one (4j)
Yield: 88.2%, white solid; m. p. 112–113°C (lit. [26]: mp 114.0–114.6°C). – 1H NMR (600 MHz, CDCl3): δ=7.89 (d, 1H, J=7.8 Hz), 7.77 (td, 1H, J=7.8 Hz, 1.2 Hz), 7.69–7.67 (m, 3H), 7.60–7.56 (m, 3H), 6.81 (s, 1H). – 13C NMR (150 MHz, CDCl3): δ=168.8, 145.5, 136.1, 134.5, 132.4, 130.4, 126.2, 125.9, 125.7, 123.3, 85.6. – HRMS [(+)-(ESI)]: m/z=311.0348 (calcd. 311.0353 for C15H10F3O2S, [M+H]+).
4.2.21 (R/S)-3-(naphthalen-2-ylthio)isobenzofuran-1(3H)-one (4k)
Yield: 68.5%, white solid; m. p. 99–101°C (lit. [26]: 97.5–97.8°C). – 1H NMR (600 MHz, CDCl3): δ=8.05 (s, 1H), 7.79–7.70 (m, 6H), 7.56 (dd, 1H, J=8.4 Hz, 1.8 Hz), 7.50–7.48 (m, 3H), 6.80 (s, 1H). – 13C NMR (150 MHz, CDCl3): δ=169.1, 146.0, 134.3, 133.4, 133.0, 132.9, 130.1, 130.0, 128.7, 127.9, 127.8, 127.7, 126.9, 126.7, 126.2, 125.5, 123.4, 86.7. – HRMS [(+)-(ESI)]: m/z=293.0636 (calcd. 293.0641 for C18H13O2S, [M+H]+).
4.2.22 (R/S)-3-(1H-benzo[d]imidazol-2-ylthio)isobenzofuran-1(3H)-one (4l)
Yield: 64.1%, white solid; m. p. 86–88°C. – 1H NMR (600 MHz, CDCl3): δ=7.94 (d, 1H, J=7.8 Hz), 7.77–7.74 (m, 1H), 7.71 (d, 1H, J=8.4 Hz), 7.64–7.61 (m, 3H), 7.31–7.30 (m, 2H), 7.23 (s, 1H). – 13C NMR (150 MHz, CDCl3): δ=168.7, 144.9, 144.1, 135.0, 130.8, 125.9, 125.7, 123.5, 123.4, 84.9. – HRMS [(+)-(ESI)]: m/z=283.0549 (calcd. 283.0544 for C15H11N2O2S, [M+H]+).
4.2.23 (R/S)-3-(thiophen-2-ylthio)isobenzofuran-1(3H)-one (4m)
Yield: 62.3%, white solid; m. p. 99–101°C. – 1H NMR (600 MHz, CDCl3): δ=7.73–7.69 (m, 2H), 7.65 (dd, 1H, J=7.8 Hz, 0.6 Hz), 7.50 (t, 1H, J=7.2 Hz), 7.32 (dd, 1H, J=7.2 Hz, 1.2 Hz), 7.12 (dd, 1H, J=3.6 Hz, 1.2 Hz), 6.89–6.88 (m, 1H), 6.55 (s, 1H). – 13C NMR (150 MHz, CDCl3) δ=168.9, 145.8, 137.6, 134.3, 132.2, 130.0, 127.7, 126.2, 125.3, 123.4, 86.2. – HRMS [(+)-(ESI)]: m/z=249.0054 (calcd. 249.0049 for C12H9O2S2, [M+H]+).
4.3 Biological assay
Twenty-four phthalide derivatives (3a–j, 4a–m) were screened in vitro for their antifungal activities against nine phytopathogenic fungi (i.e. FS, BP, CL, FM, FG, AA, PO, FV, and AB). Potato dextrose agar (PDA) medium was prepared in the flasks and sterilized. Compounds 3a–j and 4a–m were dissolved in acetone before mixing with PDA, and the concentration of test compounds in the medium was fixed at 50 μg mL−1. The medium was then poured into sterilized Petri dishes. All types of fungi were incubated in PDA at T=28±1°C for 5 days to get new mycelium for the antifungal assays, and a mycelia disk of approximately 5 mm diameter cut from culture medium was picked up with a sterilized inoculation needle and inoculated in the center of the PDA Petri dishes. The inoculated Petri dishes were incubated at 28±1°C for 4 days. Acetone without addition of any compound mixed with PDA served as the control. Hymexazol, a commercially available agricultural fungicide, was used at 50 μg mL−1 as a positive control. For each treatment, three replicates were conducted. The radial growths of the fungal colonies were measured, and the data were statistically analyzed. The inhibitory effects of the test compounds on the fungi in vitro were calculated by the formula:
where C represents the diameter of fungi growth on untreated PDA, and T represents the diameter of fungi on treated PDA.
Acknowledgments
This research was supported by the Guizhou Provincial Engineering Laboratory for Chemical Drug R&D (No. [2016]5402), Guizhou Province Science and Technology Fund (No. [2016]2848, [2017]2835 and [2019]1269), Guiyang Science and Technology Fund (No. [2017]30-28) and the opening foundation of the key laboratory of green pesticide and agricultural bioengineering, Ministry of Education, Guizhou University (No. 2018GDGP0101).
References
[1] J. J. Beck, S. C. Chou, J. Nat. Prod. 2007, 70, 891–900.10.1021/np0605586Suche in Google Scholar PubMed
[2] R. Karmakar, P. Pahari, D. Mal, Chem. Rev.2014, 114, 6213–6284.10.1021/cr400524qSuche in Google Scholar PubMed
[3] B. M. Dietz, D. Liu, G. K. Hagos, P. Yao, A. Schinkovitz, S. M. Pro, S. Deng, N. R. Farnsworth, G. F. Pauli, R. B. van Breemen, J. L. Bolton, Chem. Res. Toxicol. 2008, 21, 1939–1948.10.1021/tx8001274Suche in Google Scholar PubMed PubMed Central
[4] K. Juárez-Reyes, G. E. Ángeles-López, I. Rivero-Cruz, R. Bye, R. Mata, Pharm. Biol.2014, 52, 14–20.10.3109/13880209.2013.805235Suche in Google Scholar PubMed
[5] L. Zhang, J. R. Du, J. Wang, D. K. Yu, Y. S. Chen, Y. He, C. Y. Wang, Yakugaku. Zasshi.2009, 129, 855–859.10.1248/yakushi.129.855Suche in Google Scholar PubMed
[6] H. Xu, Y. Feng, Acta Pharm. Sin. 2001, 36, 329–333.10.1023/A:1004855924268Suche in Google Scholar
[7] M. Miyazawa, T. Tsukamoto, J. Anzai, Y. Ishikawa, J. Agric. Food Chem.2004, 52, 4401–4405.10.1021/jf0497049Suche in Google Scholar PubMed
[8] T. Tsukamoto, Y. Ishikawa, M. Miyazawa, J. Agric. Food Chem.2005, 53, 5549–5553.10.1021/jf050110vSuche in Google Scholar PubMed
[9] C. M. Passreiter, Y. Akhtar, M. B. Isman, Z. Naturforsch. 2005, 60c, 411–414.10.1515/znc-2005-5-608Suche in Google Scholar PubMed
[10] X. L. Yang, S. Zhang, Q. B. Hu, D. Q. Luo, Y. Zhang, J. Antibiot. 2011, 64, 723–727.10.1038/ja.2011.82Suche in Google Scholar PubMed
[11] K. M. Meepagala, G. Sturtz, D. E. Wedge, K. K. Schrader, S. O. Duke, J. Chem. Ecol. 2005, 31, 1567–1578.10.1007/s10886-005-5798-8Suche in Google Scholar PubMed
[12] X. D. Qin, Z. J. Dong, J. K. Liu, L. M. Yang, R. R. Wang, T. T. Zheng, Y. Lu, Y. S. Wu, Q. T. Zheng, Helv. Chim. Acta2006, 89, 127−133.10.1002/hlca.200690004Suche in Google Scholar
[13] K. Yoganathan, C. Rossant, S. Ng, Y. Huang, M. S. Butler, A. D. Buss, J. Nat. Prod. 2003, 66, 1116−1117.10.1021/np030146mSuche in Google Scholar PubMed
[14] X. Diao, P. Deng, C. Xie, X. Li, D. Zhong, Y. Zhang, X. Chen, Drug Metab. Dispos. 2013, 41, 430−444.10.1124/dmd.112.049684Suche in Google Scholar PubMed
[15] D. Floryk, E. Huberman, Cancer Lett. 2006, 231, 20−29.10.1016/j.canlet.2005.01.006Suche in Google Scholar PubMed
[16] K. Liberra, R. Jansen, U. Lindequist, Pharmazie1998, 53, 578−581.Suche in Google Scholar
[17] M. Tada, K. Chiba, Agric. Biol. Chem.1984, 48, 1367−1369.10.1080/00021369.1984.10866324Suche in Google Scholar
[18] H. Xu, L. L. Fan, Eur. J. Med. Chem.2011, 46, 364–369.10.1016/j.ejmech.2010.10.022Suche in Google Scholar PubMed
[19] H. Xu, L. L. Fan, Eur. J. Med. Chem.2011, 46, 1919–1925.10.1016/j.ejmech.2011.02.035Suche in Google Scholar PubMed
[20] K. B. Sloan, S. A. M. Koch, J. Org. Chem.1983, 48, 635–640.10.1021/jo00153a002Suche in Google Scholar
[21] D. C. Erwin, J. J. Sims, D. E. Borum, J. R. Childers, Phytopathology1971, 61, 964–967.10.1094/Phyto-61-964Suche in Google Scholar
[22] N. Martins, L. Barros, M. Henriques, S. Silva, I. C. F. R. Ferreira, Ind. Crops Prod. 2015, 74, 648–670.10.1016/j.indcrop.2015.05.067Suche in Google Scholar
[23] S. L. Zhang, Y. F. Zhao, Y. J. Liu, D. Chen, W. H. Lan, Q. L. Zhao, C. C. Dong, L. Xia, P. Gong, Eur. J. Med. Chem.2010, 45, 3504–3510.10.1016/j.ejmech.2010.05.016Suche in Google Scholar PubMed
[24] F. Englaender, H. Aus der Fuenten, P. Riegger, K. D. Steffen, G. Weisgerber, G. Zoche, Chem. Ztg. 1979, 103, 9–17.Suche in Google Scholar
[25] S. Ponra, A. Nyadanu, S. Maurin, L. El Kaïm, L. Grimaud, M. R. Vitale, Synthesis2018, 50, 1331–1342.10.1055/s-0036-1591733Suche in Google Scholar
[26] M. Sakulsombat, M. Angelin, O. Ramström, Tetrahedron Lett. 2010, 51, 75–78.10.1016/j.tetlet.2009.10.079Suche in Google Scholar
©2019 Walter de Gruyter GmbH, Berlin/Boston
Artikel in diesem Heft
- Frontmatter
 - In this Issue
 - Research Articles
 - Electron densities of two cyclononapeptides from invariom application
 - Crystal structures, Hirshfeld surface analysis and Pixel energy calculations of three trifluoromethylquinoline derivatives: further analyses of fluorine close contacts in trifluoromethylated derivatives
 - Synthesis and antifungal activities of 3-substituted phthalide derivatives
 - Unexpected isolation of a cyclohexenone derivative
 - Preparation and structure of 4-(dimethylamino)thiopivalophenone – intermolecular interactions in the crystal
 - A new binuclear NiII complex with tetrafluorophthalate and 2,2′-bipyridine ligands: synthesis, crystal structure and magnetic properties
 - Two mononuclear zinc(II) complexes constructed by two types of phenoxyacetic acid ligands: syntheses, crystal structures and fluorescence properties
 - Investigation of the reactivity of 4-amino-5-hydrazineyl-4H-1,2, 4-triazole-3-thiol towards some selected carbonyl compounds: synthesis of novel triazolotriazine-, triazolotetrazine-, and triazolopthalazine derivatives
 - Synthesis and structural characterization of a Ni(II) coordination polymer with a tripodal 4-imidazolyl-functional ligand
 - Crystal structure and photocatalytic degradation properties of a new two-dimensional zinc coordination polymer based on 4,4ʹ-oxy-bis(benzoic acid)
 - Intermetallics of the types REPd3X2 and REPt3X2 (RE=La–Nd, Sm, Gd, Tb; X=In, Sn) with substructures featuring tin and In atoms in distorted square-planar coordination
 - A 119Sn Mössbauer-spectroscopic characterization of the diamagnetic birefringence material Sn2B5O9Cl
 - Synthesis, crystal structure and photoluminescence of the salts Cation+ [M(caffeine)Cl]− with Cation+=NnBu4+, AsPh4+ and M==Zn(II), Pt(II)
 - Synthesis and characterization of two bifunctional pyrazole-phosphonic acid ligands
 - A β-ketoiminato palladium(II) complex for palladium deposition
 - Orthoamide und Iminiumsalze, XCVIa. Push-pull-substituierte 1,3,5-Hexatriene aus Orthoamiden von Alkincarbonsäuren und Birckenbach-analogen Acetophenonen
 - Orthoamide und Iminiumsalze, IIICa. Weitere Ergebnisse bei der Umsetzung von Orthoamiden der Alkincarbonsäuren mit CH2- und CH2/NH-aciden Verbindungen
 
Artikel in diesem Heft
- Frontmatter
 - In this Issue
 - Research Articles
 - Electron densities of two cyclononapeptides from invariom application
 - Crystal structures, Hirshfeld surface analysis and Pixel energy calculations of three trifluoromethylquinoline derivatives: further analyses of fluorine close contacts in trifluoromethylated derivatives
 - Synthesis and antifungal activities of 3-substituted phthalide derivatives
 - Unexpected isolation of a cyclohexenone derivative
 - Preparation and structure of 4-(dimethylamino)thiopivalophenone – intermolecular interactions in the crystal
 - A new binuclear NiII complex with tetrafluorophthalate and 2,2′-bipyridine ligands: synthesis, crystal structure and magnetic properties
 - Two mononuclear zinc(II) complexes constructed by two types of phenoxyacetic acid ligands: syntheses, crystal structures and fluorescence properties
 - Investigation of the reactivity of 4-amino-5-hydrazineyl-4H-1,2, 4-triazole-3-thiol towards some selected carbonyl compounds: synthesis of novel triazolotriazine-, triazolotetrazine-, and triazolopthalazine derivatives
 - Synthesis and structural characterization of a Ni(II) coordination polymer with a tripodal 4-imidazolyl-functional ligand
 - Crystal structure and photocatalytic degradation properties of a new two-dimensional zinc coordination polymer based on 4,4ʹ-oxy-bis(benzoic acid)
 - Intermetallics of the types REPd3X2 and REPt3X2 (RE=La–Nd, Sm, Gd, Tb; X=In, Sn) with substructures featuring tin and In atoms in distorted square-planar coordination
 - A 119Sn Mössbauer-spectroscopic characterization of the diamagnetic birefringence material Sn2B5O9Cl
 - Synthesis, crystal structure and photoluminescence of the salts Cation+ [M(caffeine)Cl]− with Cation+=NnBu4+, AsPh4+ and M==Zn(II), Pt(II)
 - Synthesis and characterization of two bifunctional pyrazole-phosphonic acid ligands
 - A β-ketoiminato palladium(II) complex for palladium deposition
 - Orthoamide und Iminiumsalze, XCVIa. Push-pull-substituierte 1,3,5-Hexatriene aus Orthoamiden von Alkincarbonsäuren und Birckenbach-analogen Acetophenonen
 - Orthoamide und Iminiumsalze, IIICa. Weitere Ergebnisse bei der Umsetzung von Orthoamiden der Alkincarbonsäuren mit CH2- und CH2/NH-aciden Verbindungen